Eli Lilly's experimental weekly triple-hormone injection cut breathing interruptions during sleep in adults with and without type 2 diabetes, alongside substantial weight loss, over 80 weeks. Retatrutide, an investigational once-weekly injection from Eli Lilly, lowered the severity of obstructive sleep…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.